MYC and Miyoshi myopathy: Secondly, gene expression profiling of IMiD-resistant MM cell lines and small numbers of IMiD-resistant MM patients showed dysregulation of Wnt/β-catenin activity, leading to upregulated cyclin D1 and MYC (80).